Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPAR levels

Planta Medica

Volumn 77, Issue 17, 2011, Pages 1876-1882

  Chang, Chia Ju ^a   Tzeng, Thing Fong ^b   Liou, Shorong Shii ^c   Chang, Yuan Shiun ^a   Liu, I Min ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Pao Chien Hospital   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

Author keywords

acyl CoA oxidase; cytochrome P450 isoform 4A1; high fat diet; kaempferol; peroxisome proliferatoractivated receptor

Indexed keywords

ACYL COENZYME A OXIDASE; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; CHOLESTEROL; CYTOCHROME P450 4A1; FATTY ACID; FENOFIBRATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KAEMPFEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WEIGHT REDUCTION;

ACYL-COA OXIDASE; ADIPOCYTES; ADMINISTRATION, ORAL; ALKANE 1-MONOOXYGENASE; ANIMALS; DIET, HIGH-FAT; DOSE-RESPONSE RELATIONSHIP, DRUG; FENOFIBRATE; GENE EXPRESSION REGULATION; HYPOLIPIDEMIC AGENTS; KAEMPFEROLS; LIPID METABOLISM; LIPIDS; LIVER; MALE; PPAR ALPHA; RATS; RATS, WISTAR; STEROL REGULATORY ELEMENT BINDING PROTEINS; WEIGHT GAIN;

RATTUS;

EID: 82155197195     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1279992     Document Type: Article

References (29)

1. McCarthy M I. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010 363 2339-2350
2. Tilg H, Moschen A R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006 6 772-783 (Pubitemid 44453463)
3. Padwal R S., Majumdar S R. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007 369 71-77 (Pubitemid 46027230)
4. Nijveldt R J., van Nood E, van Hoorn D E., Boelens P G., van Norren K, van Leeuwen P A. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001 74 418-425 (Pubitemid 32880250)
5. Prince P S., Sathya B. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Eur J Pharmacol 2010 635 142-148
6. Ong K C., Khoo H E. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci 2000 67 1695-1705
7. Sclafani A, Springer D. Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiol Behav 1976 17 461-471
8. van Heek M, Compton D S., France C F., Tedesco R P., Fawzi B, Graziano M P., Sybertz E J., Strader C D., Davis jr. H R. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997 99 385-390 (Pubitemid 27414794)
9. Zhou J Y., Zhou S W., Zhang K B., Tang J L., Guang L X., Ying Y, Xu Y, Zhang L, Li D D. Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. Biol Pharm Bull 2008 31 1169-1176 (Pubitemid 351871171)
10. Friedewald W T., Levy R I., Fredrickson D S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972 18 499-502
11. Abbott R D., Wilson P W., Kannel W B., Castelli W P. High density lipoprotein-cholesterol, total cholesterol screening and myocardial infarction. The Framingham Study. Arterosclerosis 1988 8 207-211
12. Shanmugasundaram K R., Visvanathan A, Dhandapani K, Srinivasan N, Rasappan P, Gilbert R, Alladi S, Kancharla S, Vasanthi N. Effect of high-fat diet on cholesterol distribution in plasma lipoproteins, cholesterol esterifying activity in leucocytes, and erythrocyte membrane components studied: importance of body weight. Am J Clin Nutr 1986 44 805-815 (Pubitemid 17209001)
13. Folch J, Lees M, Sloane-Stanley G H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957 226 497-506
14. Brunt E M., Janney C G., Di Bisceglie A M., Neuschwander-Tetri B A., Bacon B R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999 94 2467-2474 (Pubitemid 29420675)
15. Park C H., Yamabe N, Noh J S., Kang K S., Tanaka T, Yokozawa T. The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice. Biol Pharm Bull 2009 32 1734-1740
16. Mancini F P., Lanni A, Sabatino L, Moreno M, Giannino A, Contaldo F, Colantuoni V, Goglia F. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett 2001 491 154-158 (Pubitemid 32172021)
17. Björntorp P. Number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism 1971 20 703-713
18. Paccaud F, Schlüter-Fasmeyer V, Wietlisbach V, Bovet P. Dyslipidemia and abdominal obesity: an assessment in three general populations. J Clin Epidemiol 2000 53 393-400 (Pubitemid 30216478)
19. Malloy M J., Kane J P. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 2001 47 111-136 (Pubitemid 33791976)
20. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001 104 365-372 (Pubitemid 32666962)
21. Ansell B J., Watson K E., Fogelman A M., Navab M, Fonarow G C. High-density lipoprotein function recent advances. J Am Coll Cardiol 2005 46 1792-1798 (Pubitemid 41579798)
22. Hartog M G. L., Feskens E J. M., Hollman P C. H., Katan M B., Kromhouy D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993 342 1007-1011 (Pubitemid 23314801)
23. Fang X K., Gao J, Zhu D N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci 2008 82 615-622
24. Mandard S, Muller M, Kersten S. Peroxisome proliferators-activated receptor alpha target genes. Cell Mol Life Sci 2004 61 393-416 (Pubitemid 38316578)
25. Hodge H C., Downs W L., Panner B S., Smith D W., Maynard E A. Oral toxicity and metabolism of diuron (N-(3,4-dichlorophenyl)-N,N-dimethylurea) in rats and dogs. Food Chem Toxicol 1967 5 513-531
26. Fatehi-Hassanabad Z, Chan C. Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function. Nutr Metab 2005 2 1-12
27. Briggs M R., Yokoyama C, Wang X, Brown M S., Goldstein J L. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promotor. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 1993 268 14490-14496 (Pubitemid 23195580)
28. Ginsberg H N. REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia. J Clin Endocrinol Metab 2006 91 383-392 (Pubitemid 43236897)
29. Park C H., Yamabe N, Noh J S., Kang K S., Tanaka T, Yokozawa T. The beneficial effects of morroniside on the inflammatory response and lipid metabolism in the liver of db/db mice. Biol Pharm Bull 2009 32 1734-1740